A living WHO guideline on drugs for covid-19
Abstract Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will...
Publications
3 shownInterleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
BACKGROUND: The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS: We evaluated tocilizumab ...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 4,456
- Institution
- LRS Institute of Tuberculosis and Respiratory Diseases
External Links
Identifiers
- ORCID
- 0000-0002-5338-2538
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.